APO Research
Talk to an analyst

APO RESEARCH · REPORT

Weight-loss Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Weight-loss Drugs Market Analysis and Forecast 2026-2032

19 December 2025208 pages

Choose your research edition.

Industry ResearchWeight-loss Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Weight-loss Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Weight-loss Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Weight-loss Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Weight-loss Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Weight-loss Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Weight-loss Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Weight-loss Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Weight-loss Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Weight-loss Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Weight-loss Drugs include Ajinomoto Co. Inc., Amway Corp., Currax, Glanbia PLC, GlaxoSmithKline PLC, Health and Nutrition Ltd., Herbalife Nutrition Ltd., Kellogg Company and Kraft Heinz Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Weight-loss Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Weight-loss Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Weight-loss Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Weight-loss Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Weight-loss Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Weight-loss Drugs sales, projected growth trends, production technology, application and end-user industry.

Weight-loss Drugs Segment by Company

Ajinomoto Co. Inc.

Amway Corp.

Currax

Glanbia PLC

GlaxoSmithKline PLC

Health and Nutrition Ltd.

Herbalife Nutrition Ltd.

Kellogg Company

Kraft Heinz Company

Novo Nordisk

PepsiCo

Roar Ambition

Swiss Research Labs Ltd.

Ultimate life ltd

Wolfson Berg Ltd

Nestle

Abbott

Weight-loss Drugs Segment by Type

Powder

Softgels

Pills

Liquid

Others

Weight-loss Drugs Segment by Application

Hospitals and Clinics

Pharmacy

Online Sales

Others

Weight-loss Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight-loss Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Weight-loss Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight-loss Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Weight-loss Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Weight-loss Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Weight-loss Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Weight-loss Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Powder Major Manufacturers Table 3. Softgels Major Manufacturers Table 4. Pills Major Manufacturers Table 5. Liquid Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Weight-loss Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals and Clinics Major Manufacturers Table 9. Pharmacy Major Manufacturers Table 10. Online Sales Major Manufacturers Table 11. Others Major Manufacturers Table 12. Weight-loss Drugs Industry Trends Table 13. Weight-loss Drugs Industry Drivers Table 14. Weight-loss Drugs Industry Opportunities and Challenges Table 15. Weight-loss Drugs Industry Restraints Table 16. Global Weight-loss Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Weight-loss Drugs Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Weight-loss Drugs Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Weight-loss Drugs Revenue Market Share by Region (2021-2026) Table 20. Global Weight-loss Drugs Revenue Market Share by Region (2027-2032) Table 21. Global Weight-loss Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Weight-loss Drugs Sales by Region (2021-2026) & (K Units) Table 23. Global Weight-loss Drugs Sales by Region (2027-2032) & (K Units) Table 24. Global Weight-loss Drugs Sales Market Share by Region (2021-2026) Table 25. Global Weight-loss Drugs Sales Market Share by Region (2027-2032) Table 26. Global Weight-loss Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Weight-loss Drugs Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Weight-loss Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Weight-loss Drugs Sales Market Share by Manufacturers (2021-2026) Table 30. Global Weight-loss Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Weight-loss Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Weight-loss Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Weight-loss Drugs Manufacturers, Product Type & Application Table 34. Global Weight-loss Drugs Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Weight-loss Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Weight-loss Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Weight-loss Drugs Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Weight-loss Drugs Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Weight-loss Drugs Revenue Market Share by Type (2021-2026) Table 41. Global Weight-loss Drugs Revenue Market Share by Type (2027-2032) Table 42. Global Weight-loss Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 44. Global Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 45. Global Weight-loss Drugs Sales Market Share by Type (2021-2026) Table 46. Global Weight-loss Drugs Sales Market Share by Type (2027-2032) Table 47. Global Weight-loss Drugs Price by Type (2021-2026) & (US$/Unit) Table 48. Global Weight-loss Drugs Price by Type (2027-2032) & (US$/Unit) Table 49. Global Weight-loss Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Weight-loss Drugs Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Weight-loss Drugs Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Weight-loss Drugs Revenue Market Share by Application (2021-2026) Table 53. Global Weight-loss Drugs Revenue Market Share by Application (2027-2032) Table 54. Global Weight-loss Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 56. Global Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Weight-loss Drugs Sales Market Share by Application (2021-2026) Table 58. Global Weight-loss Drugs Sales Market Share by Application (2027-2032) Table 59. Global Weight-loss Drugs Price by Application (2021-2026) & (US$/Unit) Table 60. Global Weight-loss Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. Ajinomoto Co. Inc. Company Information Table 62. Ajinomoto Co. Inc. Business Overview Table 63. Ajinomoto Co. Inc. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio Table 65. Ajinomoto Co. Inc. Recent Development Table 66. Amway Corp. Company Information Table 67. Amway Corp. Business Overview Table 68. Amway Corp. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Amway Corp. Weight-loss Drugs Product Portfolio Table 70. Amway Corp. Recent Development Table 71. Currax Company Information Table 72. Currax Business Overview Table 73. Currax Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Currax Weight-loss Drugs Product Portfolio Table 75. Currax Recent Development Table 76. Glanbia PLC Company Information Table 77. Glanbia PLC Business Overview Table 78. Glanbia PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Glanbia PLC Weight-loss Drugs Product Portfolio Table 80. Glanbia PLC Recent Development Table 81. GlaxoSmithKline PLC Company Information Table 82. GlaxoSmithKline PLC Business Overview Table 83. GlaxoSmithKline PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio Table 85. GlaxoSmithKline PLC Recent Development Table 86. Health and Nutrition Ltd. Company Information Table 87. Health and Nutrition Ltd. Business Overview Table 88. Health and Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 90. Health and Nutrition Ltd. Recent Development Table 91. Herbalife Nutrition Ltd. Company Information Table 92. Herbalife Nutrition Ltd. Business Overview Table 93. Herbalife Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 95. Herbalife Nutrition Ltd. Recent Development Table 96. Kellogg Company Company Information Table 97. Kellogg Company Business Overview Table 98. Kellogg Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Kellogg Company Weight-loss Drugs Product Portfolio Table 100. Kellogg Company Recent Development Table 101. Kraft Heinz Company Company Information Table 102. Kraft Heinz Company Business Overview Table 103. Kraft Heinz Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Kraft Heinz Company Weight-loss Drugs Product Portfolio Table 105. Kraft Heinz Company Recent Development Table 106. Novo Nordisk Company Information Table 107. Novo Nordisk Business Overview Table 108. Novo Nordisk Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Novo Nordisk Weight-loss Drugs Product Portfolio Table 110. Novo Nordisk Recent Development Table 111. PepsiCo Company Information Table 112. PepsiCo Business Overview Table 113. PepsiCo Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. PepsiCo Weight-loss Drugs Product Portfolio Table 115. PepsiCo Recent Development Table 116. Roar Ambition Company Information Table 117. Roar Ambition Business Overview Table 118. Roar Ambition Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Roar Ambition Weight-loss Drugs Product Portfolio Table 120. Roar Ambition Recent Development Table 121. Swiss Research Labs Ltd. Company Information Table 122. Swiss Research Labs Ltd. Business Overview Table 123. Swiss Research Labs Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio Table 125. Swiss Research Labs Ltd. Recent Development Table 126. Ultimate life ltd Company Information Table 127. Ultimate life ltd Business Overview Table 128. Ultimate life ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Ultimate life ltd Weight-loss Drugs Product Portfolio Table 130. Ultimate life ltd Recent Development Table 131. Wolfson Berg Ltd Company Information Table 132. Wolfson Berg Ltd Business Overview Table 133. Wolfson Berg Ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Wolfson Berg Ltd Weight-loss Drugs Product Portfolio Table 135. Wolfson Berg Ltd Recent Development Table 136. Nestle Company Information Table 137. Nestle Business Overview Table 138. Nestle Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Nestle Weight-loss Drugs Product Portfolio Table 140. Nestle Recent Development Table 141. Abbott Company Information Table 142. Abbott Business Overview Table 143. Abbott Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Abbott Weight-loss Drugs Product Portfolio Table 145. Abbott Recent Development Table 146. North America Weight-loss Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. North America Weight-loss Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. North America Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 149. North America Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 150. North America Weight-loss Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 151. North America Weight-loss Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 152. North America Weight-loss Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. North America Weight-loss Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. North America Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 155. North America Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 156. North America Weight-loss Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 157. North America Weight-loss Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 158. North America Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. North America Weight-loss Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. North America Weight-loss Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. North America Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. North America Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 163. North America Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 164. North America Weight-loss Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 165. North America Weight-loss Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 166. United States Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 167. Canada Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 168. Europe Weight-loss Drugs Revenue by Type (2021-2026) & (US$ Million) Table 169. Europe Weight-loss Drugs Revenue by Type (2027-2032) & (US$ Million) Table 170. Europe Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 171. Europe Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 172. Europe Weight-loss Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Europe Weight-loss Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Europe Weight-loss Drugs Revenue by Application (2021-2026) & (US$ Million) Table 175. Europe Weight-loss Drugs Revenue by Application (2027-2032) & (US$ Million) Table 176. Europe Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 177. Europe Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 178. Europe Weight-loss Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Europe Weight-loss Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Europe Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Europe Weight-loss Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Europe Weight-loss Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Europe Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. Europe Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 185. Europe Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 186. Europe Weight-loss Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Europe Weight-loss Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Germany Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 189. France Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 190. U.K. Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 191. Italy Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 192. Netherlands Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 193. China Weight-loss Drugs Revenue by Type (2021-2026) & (US$ Million) Table 194. China Weight-loss Drugs Revenue by Type (2027-2032) & (US$ Million) Table 195. China Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 196. China Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 197. China Weight-loss Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 198. China Weight-loss Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 199. China Weight-loss Drugs Revenue by Application (2021-2026) & (US$ Million) Table 200. China Weight-loss Drugs Revenue by Application (2027-2032) & (US$ Million) Table 201. China Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 202. China Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 203. China Weight-loss Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 204. China Weight-loss Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 205. Asia Weight-loss Drugs Revenue by Type (2021-2026) & (US$ Million) Table 206. Asia Weight-loss Drugs Revenue by Type (2027-2032) & (US$ Million) Table 207. Asia Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 208. Asia Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 209. Asia Weight-loss Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 210. Asia Weight-loss Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 211. Asia Weight-loss Drugs Revenue by Application (2021-2026) & (US$ Million) Table 212. Asia Weight-loss Drugs Revenue by Application (2027-2032) & (US$ Million) Table 213. Asia Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 214. Asia Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 215. Asia Weight-loss Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 216. Asia Weight-loss Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 217. Asia Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. Asia Weight-loss Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. Asia Weight-loss Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. Asia Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 221. Asia Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 222. Asia Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 223. Asia Weight-loss Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 224. Asia Weight-loss Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 225. Japan Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 226. South Korea Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 227. India Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 228. Australia Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 229. China Taiwan Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 230. Southeast Asia Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 231. SAMEA Weight-loss Drugs Revenue by Type (2021-2026) & (US$ Million) Table 232. SAMEA Weight-loss Drugs Revenue by Type (2027-2032) & (US$ Million) Table 233. SAMEA Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 234. SAMEA Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 235. SAMEA Weight-loss Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 236. SAMEA Weight-loss Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 237. SAMEA Weight-loss Drugs Revenue by Application (2021-2026) & (US$ Million) Table 238. SAMEA Weight-loss Drugs Revenue by Application (2027-2032) & (US$ Million) Table 239. SAMEA Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 240. SAMEA Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 241. SAMEA Weight-loss Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 242. SAMEA Weight-loss Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 243. SAMEA Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. SAMEA Weight-loss Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. SAMEA Weight-loss Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. SAMEA Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 247. SAMEA Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 248. SAMEA Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 249. SAMEA Weight-loss Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 250. SAMEA Weight-loss Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 251. Brazil Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 252. Argentina Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 253. Chile Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 254. Colombia Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 255. Peru Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 256. Saudi Arabia Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 257. Israel Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 258. UAE Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 259. Turkey Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 260. Iran Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 261. Egypt Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Table 262. Key Raw Materials Table 263. Raw Materials Key Suppliers Table 264. Weight-loss Drugs Distributors List Table 265. Weight-loss Drugs Customers List Table 266. Research Programs/Design for This Report Table 267. Authors List of This Report Table 268. Secondary Sources Table 269. Primary Sources List of Figures Figure 1. Weight-loss Drugs Image Figure 2. Global Weight-loss Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Weight-loss Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Powder Image Figure 5. Softgels Image Figure 6. Pills Image Figure 7. Liquid Image Figure 8. Others Image Figure 9. Global Weight-loss Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Weight-loss Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals and Clinics Image Figure 12. Pharmacy Image Figure 13. Online Sales Image Figure 14. Others Image Figure 15. Global Weight-loss Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Figure 17. Global Weight-loss Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Weight-loss Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Weight-loss Drugs Revenue Market Share by Region (2021-2032) Figure 20. Global Weight-loss Drugs Sales (2021-2032) & (K Units) Figure 21. Global Weight-loss Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Weight-loss Drugs Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Weight-loss Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Europe Weight-loss Drugs Sales YoY (2021-2032) & (K Units) Figure 25. China Weight-loss Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Weight-loss Drugs Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Weight-loss Drugs Sales YoY (2021-2032) & (K Units) Figure 28. Global Weight-loss Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Weight-loss Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Weight-loss Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Weight-loss Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Weight-loss Drugs Revenue Market Share by Type (2021-2032) Figure 34. Global Weight-loss Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Weight-loss Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Weight-loss Drugs Sales Market Share by Type (2021-2032) Figure 37. Global Weight-loss Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Weight-loss Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Weight-loss Drugs Revenue Market Share by Application (2021-2032) Figure 40. Global Weight-loss Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Weight-loss Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Weight-loss Drugs Sales Market Share by Application (2021-2032) Figure 43. North America Weight-loss Drugs Revenue Share by Type (2021-2032) Figure 44. North America Weight-loss Drugs Sales Share by Type (2021-2032) Figure 45. North America Weight-loss Drugs Revenue Share by Application (2021-2032) Figure 46. North America Weight-loss Drugs Sales Share by Application (2021-2032) Figure 47. North America Weight-loss Drugs Revenue Share by Country (2021-2032) Figure 48. North America Weight-loss Drugs Sales Share by Country (2021-2032) Figure 49. Europe Weight-loss Drugs Revenue Share by Type (2021-2032) Figure 50. Europe Weight-loss Drugs Sales Share by Type (2021-2032) Figure 51. Europe Weight-loss Drugs Revenue Share by Application (2021-2032) Figure 52. Europe Weight-loss Drugs Sales Share by Application (2021-2032) Figure 53. Europe Weight-loss Drugs Revenue Share by Country (2021-2032) Figure 54. Europe Weight-loss Drugs Sales Share by Country (2021-2032) Figure 55. China Weight-loss Drugs Revenue Share by Type (2021-2032) Figure 56. China Weight-loss Drugs Sales Share by Type (2021-2032) Figure 57. China Weight-loss Drugs Revenue Share by Application (2021-2032) Figure 58. China Weight-loss Drugs Sales Share by Application (2021-2032) Figure 59. Asia Weight-loss Drugs Revenue Share by Type (2021-2032) Figure 60. Asia Weight-loss Drugs Sales Share by Type (2021-2032) Figure 61. Asia Weight-loss Drugs Revenue Share by Application (2021-2032) Figure 62. Asia Weight-loss Drugs Sales Share by Application (2021-2032) Figure 63. Asia Weight-loss Drugs Revenue Share by Country (2021-2032) Figure 64. Asia Weight-loss Drugs Sales Share by Country (2021-2032) Figure 65. SAMEA Weight-loss Drugs Revenue Share by Type (2021-2032) Figure 66. SAMEA Weight-loss Drugs Sales Share by Type (2021-2032) Figure 67. SAMEA Weight-loss Drugs Revenue Share by Application (2021-2032) Figure 68. SAMEA Weight-loss Drugs Sales Share by Application (2021-2032) Figure 69. SAMEA Weight-loss Drugs Revenue Share by Country (2021-2032) Figure 70. SAMEA Weight-loss Drugs Sales Share by Country (2021-2032) Figure 71. Weight-loss Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Weight-loss Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Softgels
  • Pills
  • Liquid
  • Others
Applications
  • Hospitals and Clinics
  • Pharmacy
  • Online Sales
  • Others
Companies covered
  • Ajinomoto Co. Inc.
  • Amway Corp.
  • Currax
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Health and Nutrition Ltd.
  • Herbalife Nutrition Ltd.
  • Kellogg Company
  • Kraft Heinz Company
  • Novo Nordisk
  • PepsiCo
  • Roar Ambition
  • Swiss Research Labs Ltd.
  • Ultimate life ltd
  • Wolfson Berg Ltd
  • Nestle
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Weight-loss Drugs Market by Type
  3. 1.2.1 Global Weight-loss Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Powder
  5. 1.2.3 Softgels
  6. 1.2.4 Pills
  7. 1.2.5 Liquid
  8. 1.2.6 Others
  9. 1.3 Weight-loss Drugs Market by Application
  10. 1.3.1 Global Weight-loss Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals and Clinics
  12. 1.3.3 Pharmacy
  13. 1.3.4 Online Sales
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Weight-loss Drugs Market Dynamics
  1. 2.1 Weight-loss Drugs Industry Trends
  2. 2.2 Weight-loss Drugs Industry Drivers
  3. 2.3 Weight-loss Drugs Industry Opportunities and Challenges
  4. 2.4 Weight-loss Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Weight-loss Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Weight-loss Drugs Revenue by Region
  3. 3.2.1 Global Weight-loss Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Weight-loss Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Weight-loss Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Weight-loss Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Weight-loss Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Weight-loss Drugs Sales by Region
  9. 3.4.1 Global Weight-loss Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Weight-loss Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Weight-loss Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Weight-loss Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Weight-loss Drugs Revenue by Manufacturers
  2. 4.1.1 Global Weight-loss Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Weight-loss Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Weight-loss Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Weight-loss Drugs Sales by Manufacturers
  6. 4.2.1 Global Weight-loss Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Weight-loss Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Weight-loss Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Weight-loss Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Weight-loss Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Weight-loss Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Weight-loss Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Weight-loss Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Weight-loss Drugs Market CR5 and HHI
  16. 4.8.2 2025 Weight-loss Drugs Tier 1, Tier 2, and Tier 3
5 Weight-loss Drugs Market by Type
  1. 5.1 Global Weight-loss Drugs Revenue by Type
  2. 5.1.1 Global Weight-loss Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Weight-loss Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Weight-loss Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Weight-loss Drugs Sales by Type
  6. 5.2.1 Global Weight-loss Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Weight-loss Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Weight-loss Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Weight-loss Drugs Price by Type
6 Weight-loss Drugs Market by Application
  1. 6.1 Global Weight-loss Drugs Revenue by Application
  2. 6.1.1 Global Weight-loss Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Weight-loss Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Weight-loss Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Weight-loss Drugs Sales by Application
  6. 6.2.1 Global Weight-loss Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Weight-loss Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Weight-loss Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Weight-loss Drugs Price by Application
7 Company Profiles
  1. 7.1 Ajinomoto Co. Inc.
  2. 7.1.1 Ajinomoto Co. Inc. Company Information
  3. 7.1.2 Ajinomoto Co. Inc. Business Overview
  4. 7.1.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio
  6. 7.1.5 Ajinomoto Co. Inc. Recent Developments
  7. 7.2 Amway Corp.
  8. 7.2.1 Amway Corp. Company Information
  9. 7.2.2 Amway Corp. Business Overview
  10. 7.2.3 Amway Corp. Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amway Corp. Weight-loss Drugs Product Portfolio
  12. 7.2.5 Amway Corp. Recent Developments
  13. 7.3 Currax
  14. 7.3.1 Currax Company Information
  15. 7.3.2 Currax Business Overview
  16. 7.3.3 Currax Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Currax Weight-loss Drugs Product Portfolio
  18. 7.3.5 Currax Recent Developments
  19. 7.4 Glanbia PLC
  20. 7.4.1 Glanbia PLC Company Information
  21. 7.4.2 Glanbia PLC Business Overview
  22. 7.4.3 Glanbia PLC Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Glanbia PLC Weight-loss Drugs Product Portfolio
  24. 7.4.5 Glanbia PLC Recent Developments
  25. 7.5 GlaxoSmithKline PLC
  26. 7.5.1 GlaxoSmithKline PLC Company Information
  27. 7.5.2 GlaxoSmithKline PLC Business Overview
  28. 7.5.3 GlaxoSmithKline PLC Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio
  30. 7.5.5 GlaxoSmithKline PLC Recent Developments
  31. 7.6 Health and Nutrition Ltd.
  32. 7.6.1 Health and Nutrition Ltd. Company Information
  33. 7.6.2 Health and Nutrition Ltd. Business Overview
  34. 7.6.3 Health and Nutrition Ltd. Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio
  36. 7.6.5 Health and Nutrition Ltd. Recent Developments
  37. 7.7 Herbalife Nutrition Ltd.
  38. 7.7.1 Herbalife Nutrition Ltd. Company Information
  39. 7.7.2 Herbalife Nutrition Ltd. Business Overview
  40. 7.7.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio
  42. 7.7.5 Herbalife Nutrition Ltd. Recent Developments
  43. 7.8 Kellogg Company
  44. 7.8.1 Kellogg Company Company Information
  45. 7.8.2 Kellogg Company Business Overview
  46. 7.8.3 Kellogg Company Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Kellogg Company Weight-loss Drugs Product Portfolio
  48. 7.8.5 Kellogg Company Recent Developments
  49. 7.9 Kraft Heinz Company
  50. 7.9.1 Kraft Heinz Company Company Information
  51. 7.9.2 Kraft Heinz Company Business Overview
  52. 7.9.3 Kraft Heinz Company Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Kraft Heinz Company Weight-loss Drugs Product Portfolio
  54. 7.9.5 Kraft Heinz Company Recent Developments
  55. 7.10 Novo Nordisk
  56. 7.10.1 Novo Nordisk Company Information
  57. 7.10.2 Novo Nordisk Business Overview
  58. 7.10.3 Novo Nordisk Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novo Nordisk Weight-loss Drugs Product Portfolio
  60. 7.10.5 Novo Nordisk Recent Developments
  61. 7.11 PepsiCo
  62. 7.11.1 PepsiCo Company Information
  63. 7.11.2 PepsiCo Business Overview
  64. 7.11.3 PepsiCo Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 PepsiCo Weight-loss Drugs Product Portfolio
  66. 7.11.5 PepsiCo Recent Developments
  67. 7.12 Roar Ambition
  68. 7.12.1 Roar Ambition Company Information
  69. 7.12.2 Roar Ambition Business Overview
  70. 7.12.3 Roar Ambition Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Roar Ambition Weight-loss Drugs Product Portfolio
  72. 7.12.5 Roar Ambition Recent Developments
  73. 7.13 Swiss Research Labs Ltd.
  74. 7.13.1 Swiss Research Labs Ltd. Company Information
  75. 7.13.2 Swiss Research Labs Ltd. Business Overview
  76. 7.13.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio
  78. 7.13.5 Swiss Research Labs Ltd. Recent Developments
  79. 7.14 Ultimate life ltd
  80. 7.14.1 Ultimate life ltd Company Information
  81. 7.14.2 Ultimate life ltd Business Overview
  82. 7.14.3 Ultimate life ltd Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Ultimate life ltd Weight-loss Drugs Product Portfolio
  84. 7.14.5 Ultimate life ltd Recent Developments
  85. 7.15 Wolfson Berg Ltd
  86. 7.15.1 Wolfson Berg Ltd Company Information
  87. 7.15.2 Wolfson Berg Ltd Business Overview
  88. 7.15.3 Wolfson Berg Ltd Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Wolfson Berg Ltd Weight-loss Drugs Product Portfolio
  90. 7.15.5 Wolfson Berg Ltd Recent Developments
  91. 7.16 Nestle
  92. 7.16.1 Nestle Company Information
  93. 7.16.2 Nestle Business Overview
  94. 7.16.3 Nestle Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Nestle Weight-loss Drugs Product Portfolio
  96. 7.16.5 Nestle Recent Developments
  97. 7.17 Abbott
  98. 7.17.1 Abbott Company Information
  99. 7.17.2 Abbott Business Overview
  100. 7.17.3 Abbott Weight-loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Abbott Weight-loss Drugs Product Portfolio
  102. 7.17.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Weight-loss Drugs Market Size by Type
  2. 8.1.1 North America Weight-loss Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Weight-loss Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Weight-loss Drugs Price by Type (2021-2032)
  5. 8.2 North America Weight-loss Drugs Market Size by Application
  6. 8.2.1 North America Weight-loss Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Weight-loss Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Weight-loss Drugs Price by Application (2021-2032)
  9. 8.3 North America Weight-loss Drugs Market Size by Country
  10. 8.3.1 North America Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Weight-loss Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Weight-loss Drugs Market Size by Type
  2. 9.1.1 Europe Weight-loss Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Weight-loss Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Weight-loss Drugs Price by Type (2021-2032)
  5. 9.2 Europe Weight-loss Drugs Market Size by Application
  6. 9.2.1 Europe Weight-loss Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Weight-loss Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Weight-loss Drugs Price by Application (2021-2032)
  9. 9.3 Europe Weight-loss Drugs Market Size by Country
  10. 9.3.1 Europe Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Weight-loss Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Weight-loss Drugs Market Size by Type
  2. 10.1.1 China Weight-loss Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Weight-loss Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Weight-loss Drugs Price by Type (2021-2032)
  5. 10.2 China Weight-loss Drugs Market Size by Application
  6. 10.2.1 China Weight-loss Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Weight-loss Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Weight-loss Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Weight-loss Drugs Market Size by Type
  2. 11.1.1 Asia Weight-loss Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Weight-loss Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Weight-loss Drugs Price by Type (2021-2032)
  5. 11.2 Asia Weight-loss Drugs Market Size by Application
  6. 11.2.1 Asia Weight-loss Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Weight-loss Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Weight-loss Drugs Price by Application (2021-2032)
  9. 11.3 Asia Weight-loss Drugs Market Size by Country
  10. 11.3.1 Asia Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Weight-loss Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Weight-loss Drugs Market Size by Type
  2. 12.1.1 SAMEA Weight-loss Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Weight-loss Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Weight-loss Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Weight-loss Drugs Market Size by Application
  6. 12.2.1 SAMEA Weight-loss Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Weight-loss Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Weight-loss Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Weight-loss Drugs Market Size by Country
  10. 12.3.1 SAMEA Weight-loss Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Weight-loss Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Weight-loss Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Weight-loss Drugs Value Chain Analysis
  2. 13.1.1 Weight-loss Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Weight-loss Drugs Production Mode & Process
  6. 13.2 Weight-loss Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Weight-loss Drugs Distributors
  9. 13.2.3 Weight-loss Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst